- Home
- INTU vs ABT Comparison
INTU vs ABT Comparison
Compare INTU & ABT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | INTU | ABT |
|---|---|---|
| Founded | 1983 | 1888 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 186.7B | 222.8B |
| IPO Year | 1993 | N/A |
Fundamental Metrics
Financial Performance| Metric | INTU | ABT |
|---|---|---|
| Price | $672.65 | $125.93 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 18 | 18 |
| Target Price | ★ $811.72 | $146.61 |
| AVG Volume (30 Days) | 2.1M | ★ 6.7M |
| Earning Date | 11-20-2025 | 01-21-2026 |
| Dividend Yield | 0.71% | ★ 2.01% |
| EPS Growth | 41.77 | ★ 141.97 |
| EPS | ★ 14.57 | 7.96 |
| Revenue | $19,433,000,000.00 | ★ $43,843,000,000.00 |
| Revenue This Year | $14.85 | $7.56 |
| Revenue Next Year | $12.47 | $7.96 |
| P/E Ratio | $46.06 | ★ $15.76 |
| Revenue Growth | ★ 17.14 | 6.37 |
| 52 Week Low | $532.65 | $110.86 |
| 52 Week High | $813.70 | $141.23 |
Technical Indicators
Market Signals| Indicator | INTU | ABT |
|---|---|---|
| Relative Strength Index (RSI) | 54.87 | 49.55 |
| Support Level | $648.21 | $120.70 |
| Resistance Level | $676.54 | $129.64 |
| Average True Range (ATR) | 15.96 | 2.42 |
| MACD | 2.03 | 0.24 |
| Stochastic Oscillator | 82.77 | 59.40 |
Price Performance
Historical ComparisonAbout INTU Intuit Inc.
Intuit serves small and midsize businesses with accounting software QuickBooks and online marketing platform Mailchimp. The company also operates retail tax filing tool TurboTax, personal finance platform Credit Karma, and a suite of professional tax offerings for accountants. Founded in the mid-1980s, Intuit enjoys a dominant market share for small-to-midsize business accounting and self-serve tax filing in the US.
About ABT Abbott Laboratories
Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.